Arezoo Esteki: The Rising Role of Platelet-Rich Plasma in Precision Regenerative Care

Arezoo Esteki, Co-Founder of Bioglo Aesthetics, Infusion Nurse at Mayo Clinic, shared Mehul Malhotra’s post on LinkedIn:

“Platelet-rich plasma therapy has emerged as a promising regenerative treatment that utilizes a patient’s own platelets and growth factors to accelerate healing and tissue repair.

The therapy is increasingly being utilized across multiple medical specialties, including orthopedics, sports medicine, dermatology, cosmetic surgery, gynecology, and wound care.”

Mehul Malhotra, Associate Analyst at DelveInsight Business Research LLP, shared a post on LinkedIn:

“DelveInsight’s Platelet Rich Plasma Market Report Highlights Expanding Opportunities Across Therapeutic and Cosmetic Applications.

The global Platelet Rich Plasma (PRP) Market is experiencing substantial growth as healthcare providers increasingly adopt regenerative therapies for orthopedic disorders, sports injuries, wound healing, and aesthetic procedures.

With growing demand for minimally invasive treatment options and advancements in PRP preparation technologies, the market is poised to witness remarkable expansion over the coming years.

According to DelveInsight’s analysis, the global Platelet Rich Plasma Market was valued at approximately USD 413 million in 2022 and is projected to reach nearly USD 736 million by 2028, growing at a CAGR of 10.18 percent during the forecast period.

The increasing prevalence of musculoskeletal disorders, rising sports injuries, expanding cosmetic applications, and ongoing technological innovations in PRP systems are expected to fuel market growth worldwide.

Why is the Platelet Rich Plasma Market Growing?

Platelet-rich plasma therapy has emerged as a promising regenerative treatment that utilizes a patient’s own platelets and growth factors to accelerate healing and tissue repair.

The therapy is increasingly being utilized across multiple medical specialties, including orthopedics, sports medicine, dermatology, cosmetic surgery, gynecology, and wound care.

Several factors are contributing to the market’s upward trajectory:

• Rising prevalence of orthopedic disorders
• Increasing sports-related injuries
• Growing demand for minimally invasive procedures
• Expanding applications in aesthetic medicine
• Technological advancements in PRP preparation systems
• Rising physician and patient awareness regarding regenerative therapies

Explore detailed market forecasts, competitive benchmarking, regional analysis, company profiles, and future growth opportunities in the Platelet Rich Plasma Market Landscape.

Orthopedic Disorders Continue to Drive Demand.

Orthopedic applications remain one of the strongest growth drivers for the PRP market.

According to the International Osteoporosis Foundation, more than 8.9 million osteoporosis-related fractures occur globally every year.

Additionally, the Osteoarthritis Action Alliance estimates that approximately 242 million people worldwide were affected by symptomatic and activity-limiting osteoarthritis.

PRP therapy has demonstrated potential benefits in managing:

• Osteoarthritis
• Tennis elbow (Lateral Epicondylitis)
• Golfer’s elbow
• Plantar fasciitis
• Rotator cuff injuries
• Tendon and ligament injuries

As healthcare systems increasingly focus on regenerative treatment approaches that reduce surgical interventions and improve recovery outcomes, PRP adoption is expected to accelerate significantly.

Expanding Role of PRP in Aesthetic Medicine.

The cosmetic and aesthetic industry is rapidly emerging as a major contributor to PRP market growth.

PRP is widely utilized in procedures such as:

• Facial rejuvenation
• Acne scar treatment
• Fat grafting
• Hair restoration
• Facelifts
• Rhinoplasty
• Skin regeneration therapies

PRP’s ability to promote tissue healing, reduce inflammation, and enhance post-procedure recovery makes it an attractive option for both practitioners and patients seeking improved aesthetic outcomes.

Discover the latest market trends, growth drivers, and competitive intelligence shaping the future of the Platelet Rich Plasma Market.

Market Segmentation Insights.

PRP Systems Segment Leads the Market.

Among product categories, PRP Systems accounted for the largest market share in 2022 and are expected to maintain their leadership position throughout the forecast period.

The segment benefits from:

• Improved automation capabilities
• Consistent platelet concentration
• Enhanced processing efficiency
• Better reproducibility of treatment outcomes
• Increased physician convenience

Innovative systems such as Arthrex ACP, SmartPrep® 3 System, and fully automated platforms like Angelina are transforming PRP preparation and delivery processes.

The increasing demand for point-of-care regenerative therapies is expected to further strengthen adoption of advanced PRP systems globally.

Technological Advancements Reshaping the Competitive Landscape.

Innovation remains a critical growth catalyst within the PRP market.

Manufacturers are focusing on:

• Automated blood centrifugation technologies
• Enhanced platelet concentration methods
• Improved user-friendly system designs
• Greater procedural efficiency
• Advanced platelet-rich fibrin matrix (PRFM) technologies

These advancements are helping improve clinical outcomes while making PRP therapy more accessible across healthcare settings.

Understand regional growth patterns, key company strategies, and future revenue opportunities in the Platelet Rich Plasma Market Forecast.

North America Dominates the Global PRP Market.

North America accounted for approximately 43 percent of the global PRP market in 2022 and is expected to remain the leading regional market through 2028.

Several factors support regional dominance:

• Growing geriatric population
• High prevalence of osteoarthritis and orthopedic disorders
• Strong adoption of regenerative medicine
• Advanced healthcare infrastructure
• Rising demand for cosmetic procedures
• Continuous product launches and regulatory approvals

The increasing burden of musculoskeletal diseases and sports injuries continues to create substantial demand for PRP therapies across the United States and Canada.

Key Companies Driving Innovation.

Several leading companies are actively contributing to the growth and innovation of the PRP market, including:

• Johnson and Johnson
• Zimmer Biomet
• Arthrex
• Terumo Corporation
• Stryker
• EmCyte Corporation
• Apex Biologix
• Regen Lab SA
• Royal Biologics
• Exactech
• Nuo Therapeutics
• CollPlant Biotechnologies
• Celling Biosciences

These organizations continue to invest heavily in research, product development, and commercialization strategies to strengthen their market positions.

Recent Developments Transforming the Market.

The PRP market has witnessed several notable advancements:

Royal Biologics

In February 2023, Royal Biologics launched BIOINCYTE™ PRFM, a next-generation PRP platform capable of converting traditional PRP into Platelet Rich Fibrin Matrix formulations.

i-Stem PRP System

In October 2022, the i-Stem PRP Kit was introduced in the UK, offering an innovative anti-shake patented system designed to simplify regenerative treatments.

EmCyte Corporation

EmCyte received FDA 510(k) clearance for its PurePRP® Supraphysiologic Concentrating System, enhancing its portfolio of regenerative medicine solutions.

These developments highlight the increasing pace of innovation and growing commercial opportunities within the industry.

Explore detailed market forecasts, competitive benchmarking, regional analysis, company profiles, and future growth opportunities in DelveInsight’s comprehensive Platelet Rich Plasma Market report.

Future Outlook

The Platelet Rich Plasma Market is positioned for strong growth through 2028, driven by expanding clinical applications, increasing patient awareness, and continuous technological innovation.

As healthcare providers increasingly seek effective, minimally invasive regenerative solutions, PRP therapies are expected to become an integral component of treatment strategies across orthopedics, sports medicine, aesthetics, and wound care.

The growing adoption of advanced PRP systems, favorable clinical outcomes, and increasing investments by key market players will continue to strengthen the market’s long-term growth trajectory.

Organizations that strategically invest in innovation, physician education, and market expansion initiatives will be best positioned to capitalize on the evolving opportunities within this dynamic regenerative medicine landscape.”

Stay updated with Hemostasis Today.